scholarly journals Concentration and heritability of immunoglobulin G and natural antibody immunoglobulin M in dairy and beef colostrum along with serum total protein in their calves

2022 ◽  
Author(s):  
Tess E Altvater-Hughes ◽  
Douglas C Hodgins ◽  
Lauraine Wagter-Lesperance ◽  
Shannon C Beard ◽  
Shannon L Cartwright ◽  
...  
Keyword(s):  
Total Protein ◽  
Beef Cows ◽  
Passive Transfer ◽  
Immunoglobulin M ◽  
Natural Antibody ◽  
Enzyme Linked Immunosorbent Assay ◽  
Antibody Concentration ◽  
Serum Total Protein ◽  
Beef Breed ◽  
Beef Calves

Abstract Immunoglobulin (Ig) G and natural antibody (NAb) IgM are passively transferred to the neonatal calf through bovine colostrum. Maternal IgG provides pathogen- or vaccine-specific protection and comprises about 85 percent of colostral Ig. Natural antibody IgM is less abundant but provides broad and non-specific reactivity, potentially contributing to protection against the dissemination of pathogens in the blood (septicemia) in a calf’s first days of life. In the dairy and beef industries, failure of passive transfer (FPT) of colostral Ig (serum total protein (STP) <5.2 g/dL) is still a common concern. The objectives of this study were to, i) compare colostral IgG concentrations and NAb-IgM titers between dairy and beef cows; ii) assess the effect of beef breed on colostral IgG; iii) compare passive transfer of colostral Ig in dairy and beef calves; and iv) estimate the heritability of colostral IgG and NAb-IgM. Colostrum was collected from Holstein dairy (n=282) and crossbred beef (n=168) cows at the University of Guelph dairy and beef research centres. Colostral IgG was quantified by radial immunodiffusion and NAb-IgM was quantified by an enzyme-linked immunosorbent assay. In dairy (n=308) and beef (n=169) calves, STP was estimated by digital refractometry. Beef cows had significantly greater colostral IgG (146.5 ± 9.5 SEM g/L) than dairy cows (92.4 ± 5.2 g/L, p <0.01). Beef cows with a higher proportion of Angus ancestry had significantly lower colostral IgG (125.5 ± 5.8 g/L) than cows grouped as “Other” (142.5 ± 4.9 g/L, p= 0.02). Using the FPT cut-off, 13% of dairy and 16% of beef calves had FPT; still, beef calves had a significantly larger proportion with excellent passive transfer (STP ≥6.2 g/dL, p <0.01). The heritability of colostral IgG was 0.04 (± 0.14) in dairy and 0.14 (± 0.32) in beef. Colostral NAb-IgM titers in dairy (12.12 ± 0.22, log2 (reciprocal of titer)) and beef cows (12.03 ± 0.19) did not differ significantly (p=0.71). The range of NAb-IgM titers was 9.18 to 14.60, equivalent to a 42-fold range in antibody concentration. The heritability of colostral NAb was 0.24 (± 0.16) in dairy and 0.11 (± 0.19) in beef cows. This study is the first to compare colostral NAb-IgM between dairy and beef cows. Based on the range in NAb-IgM titers and the heritability, selective breeding may improve colostrum quality and protection for neonatal calves in the early days of life.

scholarly journals Prevalence of failure of passive transfer of immunoglobulins in Holstein calves in Northern Greece and association with management practices

2017 ◽  
Vol 64 (3) ◽  
pp. 193 ◽  
Author(s):  
N. PANOUSIS (Ν. ΠΑΝΟΥΣΗΣ) ◽  
M. KRITSEPI- KONSTANTINOU (Μ. ΚΡΙΤΣΕΠΗ-ΚΩΝΣΤΑΝΤΙΝΟΥ) ◽  
E. KALAITZAKIS (Ε. ΚΑΛΑΪΤΖΑΚΗΣ) ◽  
N. GIADINIS (Ν. ΓΙΑΔΙΝΗΣ) ◽  
G. E. VALERGAKIS (Γ.Ε. ΒΑΛΕΡΓΑΚΗΣ)
Keyword(s):  
Blood Serum ◽  
Total Protein ◽  
Protein Concentration ◽  
Management Practices ◽  
Passive Transfer ◽  
Total Protein Concentration ◽  
Northern Greece ◽  
Serum Total Protein ◽  
Herd Level ◽  
Holstein Calves

Objectives of the present study were to estimate prevalence of failure of passive transfer of immunoglobulins in dairy calves in Northern Greece and to investigate factors potentially associated with it. Four hundred and thirty seven clinically healthy calves in 30 farms were included in the study. Age of calves was 18 h to 7 d. Animals were blood sampled and serum total protein concentrations were measured by a refractometer. Two thresholds of total protein concentration were used: 5.2 or 5.5 g dL 1. At calf level, an animal was considered to have failure of passive transfer of immunoblobulins when total protein concentrations were lower than the above thresholds. At herd level, a herd was considered to have failure of passive transfer of immunoglobulins when >20% of sampled calves had total protein concentration was <5.2 or <5.5 g dL-1.Moreover, data on health management on the farm were collected in a purpose-built questionnaire. At 5.2 g dL-1, 20% of the calves and 40% of the herds were considered to have failure of passive transfer of immunoglobulins; when the 5.5 g dL-1 threshold was used, respective prevalences were 26% and 53%. At herd level, mean blood serum total protein concentration tended to be positively affected by a short interval between birth and first colostrum meal, by maintenance of a stock of frozen colostrum and by establishment of a close-up group of dry cows. At calf level, the same factors had a statistically  significant positive effect on blood serum total protein concentration. Moreover, quantity of colostrum received by calves and colostrum condition were also positively related with blood serum total protein concentration. In conclusion, failure of passive transfer of immunoglobulins is a common problem in Holstein calves in Northern Greece. Increased prevalence of the problem implies that increased efforts and management practices need to be applied to ensure the adequate transferof maternal immunoglobulins to newborn calves. Also, it becomes obvious from all the above findings that many farmersare not well informed for management practices that have to implement to ensure adequate amounts of immunoglobulins tonewborn calves. Hence, dissemination of knowledge concerning best management practices for achieving adequate passiveimmunity is considered to be of significant importance.

scholarly journals Humoral Immune Response in Chromoblastomycosis during and after Therapy

2000 ◽  
Vol 7 (3) ◽  
pp. 497-500 ◽  
Author(s):  
P. Esterre ◽  
M. Jahevitra ◽  
A. Andriantsimahavandy
Keyword(s):  
Immune Response ◽  
Fungal Species ◽  
Immunoglobulin M ◽  
Enzyme Linked Immunosorbent Assay ◽  
Antibody Concentration ◽  
Therapeutic Trial ◽  
Natural Immunity ◽  
Serum Samples ◽  
Humoral Immune ◽  
Cladophialophora Carrionii

ABSTRACT A longitudinal study was carried out in Madagascar, the most important focus of chromoblastomycosis (P. Esterre, A. Andriantsimahavandy, E. Ramarcel, and J. L. Pecarrere, Am. J. Trop. Med. Hyg. 55:45–47, 1996), to investigate natural immunity to this disease. Sequential blood samples were obtained before, during, and at the end of a successful therapeutic trial with terbinafine, a new antifungal drug. Using enzyme-linked immunosorbent assay and immunoblot methods, detailed analyses of antibody concentration and antigen mapping were conducted for 136 serum samples and tentatively correlated to epidemiological and pathobiological data. Two different cytoplasmic antigens, corresponding to the two fungal species involved (Fonsecaea pedrosoi and Cladophialophora carrionii), were used to analyze the distribution of different classes of immunoglobulins. This was done with respect to the origin of the isolates, clinical and pathobiological. Although strong individual variations were noticed, some major antigens (one of 18.5 kDa specific for F. pedrosoi and two of 23.5 and 33 kDa, respectively, specific for C. carrionii) corresponded to high antibody prevalence and concentration. As some antigenic components were also detected by immunoglobulin M (IgM) and IgA antibodies, the role that these specific antibodies could play in the immune response is discussed.

scholarly journals Effect of Soy Lecithin Supplementation in Beef Cows before Calving on Colostrum Composition and Serum Total Protein and Immunoglobulin G Concentrations in Calves

Animals ◽  
2020 ◽  
Vol 10 (5) ◽  
pp. 765
Author(s):  
◽  
◽  
◽  
◽  
◽  
...  
Keyword(s):  
Immunoglobulin G ◽  
Total Protein ◽  
Dry Matter ◽  
Beef Cows ◽  
Soy Lecithin ◽  
Serum Total Protein ◽  
Fatty Acids Profile ◽  
And Control ◽  
The Impact ◽  
Total Bacteria

The aim of this study was to investigate the impact of soy lecithin supplementation in beef cow’s nutrition on colostrum composition and serum concentrations of immunoglobulin G (IgG) and serum total protein (STP) in calves. Twenty pregnant Charolaise cows were assigned to two groups. In the supplementation group (n = 10) during the last four weeks of pregnancy, soy lecithin was administrated in an amount of 20 g/cow/day. In both groups, basic composition (protein, fat, lactose, dry matter), somatic cell count (SCC), total bacteria count (TBC), IgG concentration, and fatty acids profile were determined in colostrum samples. Moreover, STP and IgG concentration were measured in calves’ blood samples on the 3rd, 7th, 14th, and 21st days of life, mothered by supplementation and control cows. Animals fed with soy lecithin before calving produced colostrum with a higher (p = 0.049) level of linoleic acid (C18:2 n-6). In addition, these results showed that soy lecithin supplementation has contributed to an increase (p = 0.029) of serum IgG in calves on the 14th day of life. The impact of such change in colostrum on IgG levels on calves serum and their half-life need further analysis.

90 Comparing Methods of Raising Twin Beef Calves

2021 ◽  
Vol 99 (Supplement_1) ◽  
pp. 3-4
Author(s):  
Eduarda M Mazzardo Bortoluzzi ◽  
Kolton Aubuchon ◽  
Nicole D Robben ◽  
Mikayla Goering ◽  
Claiborn Bronkhorst ◽  
...  
Keyword(s):  
Beef Cattle ◽  
Corpus Luteum ◽  
Birth Order ◽  
Total Protein ◽  
Uterine Horn ◽  
Reproductive Efficiency ◽  
Serum Total Protein ◽  
Blood Samples ◽  
Beef Calves ◽  
Positive Correlation

Abstract Twinning has shown promise as a means of increasing reproductive efficiency in beef cattle. The objective of this study was to compare the performance of 1) twin calves raised by their dam (twin born-twin raised; TT); 2) twin calves where one calf was grafted to another cow that lost her calf and one calf was left with their dam (twin born-single raised; TS); and 3) single born calves that were raised by their dams (single born-single raised; S). To achieve twinning, sixty-three Angus-cross cows were estrus synchronized and artificially inseminated. Seven days later, an embryo was placed into the uterine horn contralateral to the corpus luteum. Fourteen twin pairs and 11 singleton calves were produced from the described technique. Three natural twin pairs were added to the study. Birth order was recorded for twin calves (1=first calf; 2=second calf). Birth weights (BW) and blood samples for measuring serum total protein, IgG1, and IgM were collected 24 h post-calving. Calves were weighed at approximately six months of age, and a 200-d adjusted weight was calculated using the following equation: [(ADG x 200 d) + BW=A200dW]. Calf behavior data collected included interval to standing and first nursing, duration of dam nursing, and duration of non-dam nursing. Single calves had greater (P &lt; 0.001) BW compared to TT and TS. Adjusted 200-d weights were greater (P &lt; 0.05) for S compared to TS. There was a positive correlation between BW and A200dW (r=.32; P &lt; 0.05). Behavior data did not differ among raising methods. Twin-single calves had lower (P &lt; 0.05) serum IgG1 concentrations compared to S calves. Twin-Twin calves had a combined A200dW of 185 kg more than single born-single raised calves.

The Effects of Vitamin K1 and Warfarin on Prothrombin Expression in Human Hepatoblastoma (HepG2) Cells

1992 ◽  
Vol 68 (01) ◽  
pp. 040-047 ◽  
Author(s):  
C Scott Jamison ◽  
Bryan F Burkey ◽  
Sandra J Friezner Degen
Keyword(s):  
Total Protein ◽  
Hepg2 Cells ◽  
Enzyme Linked Immunosorbent Assay ◽  
Response Analysis ◽  
Secreted Protein ◽  
Mrna Levels ◽  
Vitamin K1 ◽  
Maximal Increase ◽  
Protein Levels ◽  
Warfarin Treatment

SummaryCultures of human hepatoblastoma (HepG2) cells were treated with vitamin K1 or warfarin and prothrombin antigen and mRNA levels were determined. With 3 and 6 h of 10 µg vitamin K1 treatment secreted prothrombin antigen levels, relative to total secreted protein levels, were increased 1.5-fold and 2.1-fold, respectively, over ethanol-treated control levels as determined by an enzyme-linked immunosorbent assay. Dose-response analysis with 3 h of 25 µg/ml vitamin K1 treatment demonstrated a maximal increase of 2.0-fold in secreted prothrombin antigen levels, relative to total secreted protein levels, over ethanol-treated control levels. Pulse-chase analysis with 35S-methionine and immunoprecipitation of 35S-labelled prothrombin demonstrated that, with vitamin K1 treatment (25 µg/ml, 3 h), the rate of prothrombin secretion increased approximately 2-fold and the total amount (intra- and extracellular) of prothrombin synthesized increased approximately 50% over ethanol-treated control levels. Warfarin treatment (1, 5, or 10 µg/ml, 24 h) resulted in decreases in secreted prothrombin antigen levels, relative to total protein levels to approximately 85%, 87% or 81% of ethanol-treated control levels. Analysis of total RNA isolated from these cultures by Northern and solution hybridization techniques demonstrated that prothrombin mRNA was approximately 2.1 kb and that neither vitamin K1 nor warfarin treatment affected the quantity of prothrombin mRNA (ranging from 240–350 prothrombin mRNA molecules per cell). These results demonstrate that vitamin K1 and warfarin, in addition to effects on γ-carboxylation, affect prothrombin synthesis post-transcriptionally, perhaps influencing translation, post-translational processing and/or secretion mechanisms.

TBE in Sweden

2020 ◽  
Keyword(s):  
Genetic Characterization ◽  
Immunoglobulin M ◽  
Enzyme Linked Immunosorbent Assay ◽  
Second Phase ◽  
Serum Samples ◽  
Tick Borne Encephalitis ◽  
Specific Immunoglobulin ◽  
Tick Borne Encephalitis Virus ◽  
First Time

Tick-borne encephalitis virus (TBEV) was isolated for the first time in Sweden in 1958 (from ticks and from 1 tick-borne encephalitis [TBE] patient).1 In 2003, Haglund and colleagues reported the isolation and antigenic and genetic characterization of 14 TBEV strains from Swedish patients (samples collected 1991–1994).2 The first serum sample, from which TBEV was isolated, was obtained 2–10 days after onset of disease and found to be negative for anti-TBEV immunoglobulin M (IgM) by enzyme-linked immunosorbent assay (ELISA), whereas TBEV-specific IgM (and TBEV-specific immunoglobulin G/cerebrospinal fluid [IgG/CSF] activity) was demonstrated in later serum samples taken during the second phase of the disease.

scholarly journals A Novel Mouse Monoclonal Antibody C42 against C-Terminal Peptide of Alpha-1-Antitrypsin

2021 ◽  
Vol 22 (4) ◽  
pp. 2141
Author(s):  
Srinu Tumpara ◽  
Elena Korenbaum ◽  
Mark Kühnel ◽  
Danny Jonigk ◽  
Beata Olejnicka ◽  
...  
Keyword(s):  
Monoclonal Antibody ◽  
Flow Cytometry ◽  
Western Blotting ◽  
Complex Mixture ◽  
Immunoglobulin M ◽  
Confocal Laser ◽  
Enzyme Linked Immunosorbent Assay ◽  
Dot Blot

The C-terminal-fragments of alpha1-antitrypsin (AAT) have been identified and their diverse biological roles have been reported in vitro and in vivo. These findings prompted us to develop a monoclonal antibody that specifically recognizes C-36 peptide (corresponding to residues 359–394) resulting from the protease-associated cleavage of AAT. The C-36-targeting mouse monoclonal Immunoglobulin M (IgM) antibody (containing κ light chains, clone C42) was generated and enzyme-linked immunosorbent assay (ELISA)-tested by Davids Biotechnologie GmbH, Germany. Here, we addressed the effectiveness of the novel C42 antibody in different immunoassay formats, such as dot- and Western blotting, confocal laser microscopy, and flow cytometry. According to the dot-blot results, our novel C42 antibody detects the C-36 peptide at a range of 0.1–0.05 µg and shows no cross-reactivity with native, polymerized, or oxidized forms of full-length AAT, the AAT-elastase complex mixture, as well as with shorter C-terminal fragments of AAT. However, the C42 antibody does not detect denatured peptide in SDS-PAGE/Western blotting assays. On the other hand, our C42 antibody, unconjugated as well as conjugated to DyLight488 fluorophore, when applied for immunofluorescence microscopy and flow cytometry assays, specifically detected the C-36 peptide in human blood cells. Altogether, we demonstrate that our novel C42 antibody successfully recognizes the C-36 peptide of AAT in a number of immunoassays and has potential to become an important tool in AAT-related studies.

Sign in / Sign up

Export Citation Format

Share Document